AG0019S5

138890-62-7 | 2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (4R)-

AG0019S5

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	138890-62-7
Catalog Number	AG0019S5(AGN-PC-0PNHFR)
Chemical Name	2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (4R)-
IUPAC Name	(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide
InChI	InChI=1S/C12H21N3O5S3/c1-3-14-10-8-15(5-4-6-20-2)23(18,19)12-9(10)7-11(21-12)22(13,16)17/h7,10,14H,3-6,8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1
InChI Key	HCRKCZRJWPKOAR-JTQLQIEISA-N
MDL Number	MFCD08067749
Molecular Formula	C12H21N3O5S3
Molecular Weight	383.5072
SMILES	O=S(C(S1)=CC2=C1S(N(CCCOC)C[C@@H]2NCC)(=O)=O)(N)=O
UNII	9451Z89515
Synonyms	(R)-4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-E)-1,2-thiazine-6-sulfonamide 1,1-dioxide, Azopt, brinzolamide, Brinzolamide, 138890-62-7, Azopt, Birnzolamide, AL-4862, AL 4862, C12H21N3O5S3, MFCD08067749, UNII-9451Z89515, CHEBI:3176, (4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide, (+)-4-ETHYLAMINO-3,4-DIHYDRO-2-(METHOXY)PROPYL-2H-THIENO[3,2-E]-1,2-THIAZINE-6-SULFONAMIDE-1,1-DIOXIDE, (4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide, (R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-e)-1,2-thiazine-6-sulfonamide 1,1-dioxide, DSSTox_CID_25531, DSSTox_RID_80934, DSSTox_GSID_45531, (R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide, (R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide, 138890-50-3, 2H-Thieno(3,2-e)-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (R)-, 2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (4R)-, BZ1, Q-200751, 9451Z89515, Brinzolamide [USAN], Brinzolamide (BRZ), Azopt (TN), Brinzolamide (JAN/USP/INN), 3znc, NCGC00016979-01, AK174310, Brinzolamide [USAN:USP:INN:BAN], CAS-138890-62-7, AL04862, AC1L2AKA, AC1Q6UVB, Prestwick0_000365, Prestwick1_000365, Prestwick2_000365, Prestwick3_000365, SCHEMBL24636, BSPBio_000489, (R)-4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-e)-1,2-thiazine-6-sulfonamide, MLS002153787, BIDD:GT0039, SPBio_002410, BPBio1_000539, CHEMBL220491, GTPL6797, DTXSID6045531, BDBM10885, CTK7B3009, Brinzolamide, >=98% (HPLC), HCRKCZRJWPKOAR-JTQLQIEISA-N, HMS1569I11, HMS2096I11, HMS2234K06, HMS3713I11, BCP22330, EBD27046, HY-B0588, ZINC3953037, Tox21_110722, ABP001062, BG0673, s3178, AKOS005145708, Tox21_110722_1, AC-5277, API0001760, CCG-220365, CCG-222516, CS-2788, DB01194, RL01683, NCGC00179542-03, 2H-Thieno(3,2-e)-1,2-thiazine-6-sulfonamide,4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-,1,1-dioxide,R, AN-11167, AS-35084, BC218956, CC-25206, SMR001233169, AB0012787, LS-173036, AB00513824, B4258, FT-0082471, FT-0602273, SW197152-3, AL4862;AL 4862;AL-4862, C07760, D00652, AB00513824_06, C-21387, SR-01000838832, I09-0605, SR-01000838832-2, BRD-K74913225-001-03-3, Brinzolamide, United States Pharmacopeia (USP) Reference Standard, (4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-2H,3H,4H-1$l;{6},7,2-thieno[3,2-e][1$l;{6},2]thiazine-6-sulfonamide, (4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-2H,3H,4H-1$l^{6},7,2-thieno[3,2-e][1,2]thiazine-6-sulfonamide, (4r)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2h-thieno[3,2-e][1,2]thiazine-6-sulfonamide-1,1-dioxide, (4R)-4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide, (4R)-4-ethylamino-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[4,5-e]thiazine-6-sulfonamide, (5R)-5-Ethylamino-3-(3-methoxypropyl)-2,2-dioxo-2?6,9-dithia-3-azabicyclo[4.3.0]nona-7,10-diene-8-sulfonamide, (R)- 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide, (R)-3,4-Dihydro-4-ethylamino-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide, 2H-Thieno(3,2-e)-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-,1,1-dioxide, (R)-, brimonidine, Azarga, D01MUR, Alcon brand of brinzolamide, Allphar brand of brinzolamide, cc-163, CID68844, ACN-031793, C12-H21-N3-O5-S3, CS-O-00973, Brinzolamide, 98% - 100MG 100mg, 3-(Trifluoromethyl)-benzoic acid ethyl ester, C111827,

Complexity	598
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Exact Mass	383.064g/mol
Formal Charge	0
Heavy Atom Count	23
Hydrogen Bond Acceptor Count	9
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	383.496g/mol
Monoisotopic Mass	383.064g/mol
Rotatable Bond Count	7
Topological Polar Surface Area	164A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	-0.3

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H302-H315-H319-H335
Packing Group
Precautionary statements	P261-P305+P351+P338
UN Code

Certificate of Analysis

Lot Number